WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Stock Ownership - Who owns Rhythm Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Rhythm Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Christopher Paul GermanCorporate Controller CAO2024-04-02368$41.76
$15.37kSell
Joseph ShulmanChief Technical Officer2024-03-2118,235$40.34
$735.60kSell
Jennifer Kayden LeeEVP Head of North America2024-03-209,169$38.22
$350.44kSell
Jennifer Kayden LeeEVP Head of North America2024-03-209,066$39.33
$356.57kSell
Joseph ShulmanChief Technical Officer2024-03-1915,515$39.22
$608.50kSell
Jennifer Kayden LeeEVP Head of North America2024-03-1915,515$39.22
$608.50kSell
David P. MeekerPresident and CEO2024-03-1945,494$39.22
$1.78MSell
Yann MazabraudEVP Head of International2024-03-1916,000$39.22
$627.52kSell
Hunter C. SmithChief Financial Officer2024-03-1915,515$39.22
$608.50kSell
Pamela J. CramerChief Human Resources Officer2024-03-1915,515$39.22
$608.50kSell

1 of 7

RYTM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RYTM insiders and whales buy or sell their stock.

RYTM Shareholders

What type of owners hold Rhythm Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Primecap Management Co13.39%8,052,648$307.21MInstitution
Baker Bros Advisors LP10.64%6,398,365$244.10MInstitution
Blackrock Inc10.56%6,351,750$242.32MInstitution
Ra Capital Management LP8.86%5,330,412$203.36MInstitution
Goldman Sachs Group Inc8.39%5,047,934$192.58MInstitution
Ra Capital Management LP7.25%4,360,860$166.37MInsider
Vanguard Group Inc5.37%3,226,938$123.11MInstitution
Nea Management Company LLC4.84%2,909,956$111.01MInstitution
Orbimed Advisors LLC4.57%2,750,079$104.92MInsider
Frazier Life Sciences Management LP3.94%2,371,304$90.47MInstitution

1 of 3

RYTM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RYTM87.96%12.04%Net SellingNet Selling
CORT30.65%69.35%Net BuyingNet Buying
VCEL91.22%8.78%Net SellingNet Selling
APGE82.46%11.78%Net Buying
ARVN74.74%25.26%Net SellingNet Selling
View Top Biotech Stocks

Rhythm Pharmaceuticals Stock Ownership FAQ

Who owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals (NASDAQ: RYTM) is owned by 110.88% institutional shareholders, 15.18% Rhythm Pharmaceuticals insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Rhythm Pharmaceuticals shareholder, owning 4.36M shares representing 7.25% of the company. Ra Capital Management LP's Rhythm Pharmaceuticals shares are currently valued at $166.93M.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.